Zobrazeno 1 - 10
of 87
pro vyhledávání: '"Richard S. Isaacson"'
Autor:
Robert Krikorian, Marcelle D. Shidler, Suzanne S. Summer, Patrick G. Sullivan, Andrew P. Duker, Richard S. Isaacson, Alberto J. Espay
Publikováno v:
Clinical Parkinsonism & Related Disorders, Vol 1, Iss , Pp 41-47 (2019)
Introduction: Glucose hypometabolism and insulin resistance increase risk for and accelerate progression in Parkinson's disease and neurocognitive disorders. We conducted a proof of concept trial to determine whether ketogenesis, a metabolic adaptati
Externí odkaz:
https://doaj.org/article/3df136b639f34305b8d6ef9a21d1ae3a
Autor:
Nabeel Saif, Cara Berkowitz, Susmit Tripathi, Olivia Scheyer, Emily Caesar, Hollie Hristov, Katherine Hackett, Aneela Rahman, Newman Knowlton, George Sadek, Paige Lee, Mark McInnis, Richard S. Isaacson
Publikováno v:
Alzheimer’s & Dementia: Translational Research & Clinical Interventions, Vol 6, Iss 1, Pp n/a-n/a (2020)
Abstract Introduction Low awareness of Alzheimer's disease (AD) clinical trials is a recruitment barrier. To assess whether online education may affect screening rates for AD prevention clinical trials, we conducted an initial prospective cohort stud
Externí odkaz:
https://doaj.org/article/5606a4dad42341cbb72020239c7e0d0f
Autor:
Katherine Hackett, Robert Krikorian, Tania Giovannetti, Josefina Melendez‐Cabrero, Aneela Rahman, Emily E. Caesar, Jaclyn L. Chen, Hollie Hristov, Alon Seifan, Lisa Mosconi, Richard S. Isaacson
Publikováno v:
Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, Vol 10, Iss 1, Pp 764-772 (2018)
Abstract Introduction The NIH Toolbox Cognition Battery (NIHTB‐CB) is a computer‐based protocol not yet validated for clinical assessment. Methods We administered the NIHTB‐CB and traditional neuropsychological tests to 247 Memory Disorders and
Externí odkaz:
https://doaj.org/article/ea659fbad8d74734af55623317b01185
Autor:
Aneela Rahman, Hande Jackson, Hollie Hristov, Richard S. Isaacson, Nabeel Saif, Teena Shetty, Orli Etingin, Claire Henchcliffe, Roberta Diaz Brinton, Lisa Mosconi
Publikováno v:
Frontiers in Aging Neuroscience, Vol 11 (2019)
Research indicates that after advanced age, the major risk factor for late-onset Alzheimer’s disease (AD) is female sex. Out of every three AD patients, two are females with postmenopausal women contributing to over 60% of all those affected. Sex-
Externí odkaz:
https://doaj.org/article/cff330efc7a54185939ca448e8d3ff89
Autor:
John F. Hodes, Carlee I. Oakley, James H. O'Keefe, Peilin Lu, James E. Galvin, Nabeel Saif, Sonia Bellara, Aneela Rahman, Yakir Kaufman, Hollie Hristov, Tarek K. Rajji, Anne Marie Fosnacht Morgan, Smita Patel, David A. Merrill, Scott Kaiser, Josefina Meléndez-Cabrero, Juan A. Melendez, Robert Krikorian, Richard S. Isaacson
Publikováno v:
Frontiers in Neurology, Vol 9 (2019)
The terms “prevention” and “risk reduction” are often used interchangeably in medicine. There is considerable debate, however, over the use of these terms in describing interventions that aim to preserve cognitive health and/or delay disease
Externí odkaz:
https://doaj.org/article/669a35f9fe8844a08b35d91c65ea9be7
Autor:
Matthew W. Schelke, Peter Attia, Daniel J. Palenchar, Bob Kaplan, Monica Mureb, Christine A. Ganzer, Olivia Scheyer, Aneela Rahman, Robert Kachko, Robert Krikorian, Lisa Mosconi, Richard S. Isaacson
Publikováno v:
Frontiers in Aging Neuroscience, Vol 10 (2018)
Alzheimer’s disease (AD) is a neurodegenerative dementia that affects nearly 50 million people worldwide and is a major source of morbidity, mortality, and healthcare expenditure. While there have been many attempts to develop disease-modifying the
Externí odkaz:
https://doaj.org/article/9a087b895cd5414497292343947ee060
Autor:
Jonathan P. Dyke, Lisa Mosconi, Cenai Zang, Richard S. Isaacson, Eva Schelbaum, Hooman Kamel, Lacey Loughlin, Grace Jang, Steven Jett, Silky Pahlajani, Roberta Diaz Brinton, Hollie Hristov, Niharika Malviya
Publikováno v:
Neurology
Background and ObjectivesTo examine associations between indicators of estrogen exposure from women's reproductive history and brain MRI biomarkers of Alzheimer disease (AD) in midlife.MethodsWe evaluated 99 cognitively normal women 52 ± 6 years of
Autor:
Richard S. Isaacson, Adeline L. Goss, James E. Siegler, Patrick E. Boreskie, Megan B. Richie, Zachary N. London, Robert Rook, Jennifer Hurley, Bonnie Rossow, Fawaz Al-Mufti, Amanda Chamberlain, Teresa M. Chan, Roy E. Strowd, Alexandra Miller, Romergryko G. Geocadin, Igor Rybinnik
Publikováno v:
Neurological Sciences, vol 42, iss 11
Neurological Sciences
Neurological Sciences
BACKGROUND: As medical education shifted to a virtual environment during the early coronavirus disease 2019 (COVID-19) pandemic, we evaluated how neurology podcasting may have been utilized during this period, and which features of podcasts have been
Publikováno v:
Neurology
With the rapid aging of populations, neurological disorders have become among the leading causes of disability and mortality worldwide. Most neurological conditions have a prolonged prodromal phase - even if they tend to manifest with an acute syndro
Publikováno v:
Journal of Alzheimer's Disease
Background: Alzheimer’s disease (AD) is increasingly prevalent and over 99% of drugs developed for AD have failed in clinical trials. A growing body of literature suggests that potent inhibitors of tumor necrosis factor-α (TNF-α) have potential t